The client, which is a subsidiary of a renowned global pharmaceutical brand, was established in 2020 and aims to deliver increased access to affordable and quality medicines for patients worldwide including in North America, Europe, Asia Pacific, and emerging markets. Its global portfolio includes best-in-class, iconic products for branded and complex generics, biosimilars, and over-the-counter therapeutic products.
We are extremely pleased to have benefited from DKSH’s strong presence in the market. Because they have a long-established partnership with our parent company, we are confident that they will be able to continue to help us grow in Macau.
Company representative